University of South Florida Rothman Center of Neuropsychiatry /ID# 233356 — St. Petersburg, Florida

University of South Florida Rothman Center of Neuropsychiatry /ID# 233356 is a clinical research site located in St. Petersburg, Florida, United States 33701-4708.

Crixeo Clinical Trials Trust Score: 82/100 (GOOD). This profile has not yet been claimed by the site owner.

University of South Florida Rothman Center of Neuropsychiatry /ID# 233356 has participated in 1 clinical trials.

Therapeutic areas: Anxiety Disorders,Generalized Anxiety Disorder.

Sponsors: AbbVie.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in St. Petersburg

Browse all research sites in Florida · View every site in St. Petersburg

Sponsor Feasibility Report

Trust Score: 82/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of South Florida Rothman Center of Neuropsychiatry /ID# 233356?

University of South Florida Rothman Center of Neuropsychiatry /ID# 233356 has a Crixeo Trust Score of 82/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of South Florida Rothman Center of Neuropsychiatry /ID# 233356 conducted?

University of South Florida Rothman Center of Neuropsychiatry /ID# 233356 has 1 clinical trials on record. Their work covers Anxiety Disorders,Generalized Anxiety Disorder.

Is University of South Florida Rothman Center of Neuropsychiatry /ID# 233356 accredited by Crixeo Clinical Trials?

University of South Florida Rothman Center of Neuropsychiatry /ID# 233356 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of South Florida Rothman Center of Neuropsychiatry /ID# 233356?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.